Pernix Therapeutics to Present at the Canaccord Genuity 32nd Annual Global Growth Conference
13:55 EDT 8 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX), a specialty
pharmaceutical company, today announced that Cooper Collins, President
and Chief Executive Officer, will present at the Canaccord Genuity 32nd
Annual Global Growth ...
Other Sources for this Article
Pernix Therapeutics Holdings, Inc.
Joseph T. Schepers,
800-793-2145, ext. 3002
Director, Investor Relations
jschepers@pernixtx.com
More From BioPortfolio on "Pernix Therapeutics to Present at the Canaccord Genuity 32nd Annual Global Growth Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
